Flora Growth Corp.

FLGC • Drug Manufacturers - Specialty & Generic

$7.79

— 0.00 (0.00%)

ResultadosÚltimo reporte: 31 mar 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$77.57M

Crecimiento

—

Flujo de caja

0/5

Tendencia

Negative

Evidencia

Crecimiento positivo de ingresos · 21.0%Nivel de deuda manejable · 0.76Rentabilidad débil

Datos financieros hasta: 31 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 31 mar 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$7.79

Change0.00%

Shares Out9.96M

Market Cap$77.57M

Enterprise Value$79.14M

52W Range5.86 - 47.00

Beta1.90

P/E-0.50

P/S1.88

P/B2.11

P/FCF-7.53

EV/Sales1.92

Price$7.79

Change0.00%

Shares Out9.96M

Market Cap$77.57M

Enterprise Value$79.14M

52W Range5.86 - 47.00

Beta1.90

P/E-0.50

P/S1.88

P/B2.11

P/FCF-7.53

EV/Sales1.92

EV/EBITDA-7.12

EV/FCF-7.68

Earnings Yield-200.63%

FCF Yield-13.28%

Dividend Yield0.00%

Gross Margin43.35%

Oper. Margin-30.74%

Profit Margin-30.52%

Debt/Eq0.76

Current Ratio1.01

Quick Ratio0.79

Target$185.00

Target Upside2274.84%

Target Median$185.00

Target Range30.00 - 340.00

Volume107.94K

Avg Volume96.64K

EPS Surprise-2.80

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

45/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

50/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 21.0%Nivel de deuda manejable · 0.76Rentabilidad débil

Analyst view

Analyst sentiment and price target

FLGC

Analyst sentiment

Based on 6 analyst votes · 2026-09-05

83/100

Bullish

Hold

Bearish

Precio objetivo

2026-06-19

Bajo

$30.00

Promedio

$185.00

Mediana

$185.00

Alto

$340.00

Resumen de la compañía

IPO: 5/11/2021

Industria: Drug Manufacturers - Specialty & Generic

P/B i: 2.11

Deuda / Patrimonio i: 0.76

Margen operativo: -30.74%

Margen neto: -30.52%

ROE i: -

ROIC: -

Salud financiera

Puntaje9 / 20

Deuda / Patrimonio: 0.76

Ratio corriente: 1.01

Ratio rápido: 0.79

Estado: Moderate

🧾

No hay actividad interna

No hay transacciones internas recientes disponibles.

Sobre la compañía

Flora Growth Corp.

Flora Growth Corp., along with its various subsidiaries, operates as a global enterprise specializing in the cultivation, processing, and advancement of medicinal cannabis and its derived products. The company distributes these offerings to a broad international client base, including pharmacies, medical clinics, and cosmetic companies. Its extensive portfolio encompasses a range of activities and products: Cannabis and Derivatives: This core segment involves the production and supply of medical-grade cannabis oil, alongside a spectrum of cannabis-infused medical and wellness items. Health and Personal Care: They develop and market skincare and beauty products, plant-based pharmaceuticals, phytotherapeutics, and dietary supplements. Furthermore, their offerings include a wide array of cannabidiol (CBD) products like edibles (gummies), topical applications, tinctures, and vaping solutions, as well as general lifestyle wellness items such as bath and body products, pet care, and sports recovery aids. Ancillary and Lifestyle Products: Flora Growth designs and sells loungewear crafted from hemp-derived fabrics and provides accessories for cannabis consumption, personal storage, and travel, catering to both vape and dry herb users. Food and Beverages: The company's diversified operations also include the distribution of juices, gourmet chocolates (featuring exotic fruits coated in chocolate and chocolate bars), and dried fruits, beans, and pulp sourced from Amazonian regions. These items reach consumers through various retail channels, including supermarkets, discount stores, coffee shops, restaurants, and airports. They also manufacture, promote, and distribute other beverage products. Pharmaceutical Initiatives: Flora Growth is involved in creating and distributing pain relief formulations and is actively pursuing the development of a pharmaceutical cannabinoid formula intended for Sars-Cov-2 prevention. Their products are marketed under several distinct brands, including JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya. Established in 2019, Flora Growth Corp. maintains its corporate headquarters in Toronto, Canada.

Fuente - Link

Competidores

AIM AKAN AMIX CPHI ENSC KALA KZIA MYNZ OGEN RDHL

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

📰

No hay noticias disponibles ahora

Vuelve a revisar más tarde.

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2025-11-05	-2.13	-4.93	-2.8
2025-08-01	-2.34	-4.3	-1.96
2025-05-13	-0.39	-1.56	-1.17
2025-03-24	-0.11	-16.41	-16.3
2024-11-13	-3.52	-9.38	-5.86
2024-08-12	-1.95	-8.59	-6.64
2024-05-14	-8.59	-10.94	-2.35
2024-03-29	-0.07	-0.17	-0.1
2023-11-08	-7.81	-1.95	5.86
2023-08-10	-15.63	-12.11	3.52
2023-05-15	-31.25	-23.44	7.81
2023-03-31	-70.31	-117.19	-46.88